Literature DB >> 10896354

Treatment of cystoid macular edema with non-steroidal anti-inflammatory drugs and corticosteroids.

T J Wolfensberger1, C P Herbort.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10896354     DOI: 10.1023/a:1002135518856

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


× No keyword cloud information.
  15 in total

1.  Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.

Authors:  S Grover; G A Fishman; R G Fiscella; A E Adelman
Journal:  Retina       Date:  1997       Impact factor: 4.256

2.  Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects.

Authors:  M Lafranco Dafflon; V T Tran; Y Guex-Crosier; C P Herbort
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-04       Impact factor: 3.117

3.  Cystoid macular edema as an initial symptom of inflammatory orbital pseudotumor.

Authors:  H Igarashi; S Igarashi; S Ishiko; K Fukui; A Yoshida
Journal:  Ophthalmologica       Date:  1997       Impact factor: 3.250

4.  Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients.

Authors:  R E Warwar; J D Bullock; D Ballal
Journal:  Ophthalmology       Date:  1998-02       Impact factor: 12.079

5.  Inhibition of membrane-bound carbonic anhydrase enhances subretinal fluid absorption and retinal adhesiveness.

Authors:  T J Wolfensberger; R K Chiang; A Takeuchi; M F Marmor
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2000-01       Impact factor: 3.117

6.  [Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema].

Authors:  Y Guex-Crosier; P Othenin-Girard; C P Herbort
Journal:  Klin Monbl Augenheilkd       Date:  1992-05       Impact factor: 0.700

7.  Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema.

Authors:  A J Flach; B J Dolan; A R Irvine
Journal:  Am J Ophthalmol       Date:  1987-04-15       Impact factor: 5.258

8.  Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine.

Authors:  A J Flach; L M Jampol; D Weinberg; M C Kraff; L A Yannuzzi; R V Campo; A C Neumann; H P Cupples; W H Lefler; J S Pulido
Journal:  Am J Ophthalmol       Date:  1991-11-15       Impact factor: 5.258

9.  A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis.

Authors:  S M Whitcup; K G Csaky; M J Podgor; E Y Chew; C H Perry; R B Nussenblatt
Journal:  Ophthalmology       Date:  1996-07       Impact factor: 12.079

10.  [Prevention of cystoid macular edema with diclofenac eyedrops in intracapsular cataract extraction using the Choyce Mark IX anterior chamber lens].

Authors:  C D Quentin; W Behrens-Baumann; W Gaus
Journal:  Fortschr Ophthalmol       Date:  1989
View more
  1 in total

1.  Topical dorzolamide for macular edema in the early phase after vitrectomy and epiretinal membrane removal.

Authors:  Takahiro Suzuki; Kenji Hayakawa; Yoshihiro Nakagawa; Hiromi Onouchi; Masafumi Ogata; Kenji Kawai
Journal:  Clin Ophthalmol       Date:  2013-04-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.